For individuals grappling with addiction, the transition into and out of prison can present significant challenges, according to a report released January 16, 2026. A clinic in Alaska is implementing strategies to support incarcerated individuals with addiction.

The Ninilchik Community Clinic on Alaska's Kenai Peninsula is working to address the issue. Dr. Sarah Spencer, a physician at the clinic, encountered a patient seeking a monthly buprenorphine shot for opioid use disorder. The patient feared it would be her last dose for some time due to an outstanding arrest warrant.

The Alaska Department of Corrections does not provide comprehensive access to this life-saving medication. This lack of consistent treatment during incarceration can disrupt recovery efforts and increase the risk of relapse upon release.

Buprenorphine is a medication used to treat opioid use disorder by reducing cravings and withdrawal symptoms. Consistent access to such medications is considered a critical component of addiction treatment.

The clinic's efforts highlight the need for integrated healthcare services for incarcerated individuals with addiction. Providing access to medication-assisted treatment and counseling within correctional facilities could improve outcomes and reduce recidivism rates.